DrugPatentWatch Database Preview
Ingenus Pharms Llc Company Profile
» See Plans and Pricing
What is the competitive landscape for INGENUS PHARMS LLC, and what generic and branded alternatives to INGENUS PHARMS LLC drugs are available?
INGENUS PHARMS LLC has thirteen approved drugs.
Summary for Ingenus Pharms Llc
| US Patents: | 0 |
| Tradenames: | 13 |
| Ingredients: | 13 |
| NDAs: | 13 |
Drugs and US Patents for Ingenus Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingenus Pharms Llc | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 210947-001 | Feb 18, 2020 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Ingenus Pharms Llc | CABERGOLINE | cabergoline | TABLET;ORAL | 204735-001 | Aug 1, 2018 | AB | RX | No | Yes | Start Trial | Start Trial | ||||
| Ingenus Pharms Llc | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 207562-001 | Oct 16, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Ingenus Pharms Llc | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 207563-001 | Aug 31, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Ingenus Pharms Llc | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 208789-001 | May 22, 2020 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
